162 related articles for article (PubMed ID: 36599466)
61. Tissue-specific renin-angiotensin system in pulmonary lymphangioleiomyomatosis.
Valencia JC; Pacheco-Rodriguez G; Carmona AK; Xavier J; Bruneval P; Riemenschneider WK; Ikeda Y; Yu ZX; Ferrans VJ; Moss J
Am J Respir Cell Mol Biol; 2006 Jul; 35(1):40-7. PubMed ID: 16474096
[TBL] [Abstract][Full Text] [Related]
62. Recurrent lymphangiomyomatosis after transplantation: genetic analyses reveal a metastatic mechanism.
Karbowniczek M; Astrinidis A; Balsara BR; Testa JR; Lium JH; Colby TV; McCormack FX; Henske EP
Am J Respir Crit Care Med; 2003 Apr; 167(7):976-82. PubMed ID: 12411287
[TBL] [Abstract][Full Text] [Related]
63. Vasohibin-1 and -2 in pulmonary lymphangioleiomyomatosis (LAM) cells associated with angiogenic and prognostic factors.
Inoue C; Miki Y; Saito-Koyama R; Kobayashi K; Seyama K; Okada Y; Sasano H
Pathol Res Pract; 2022 Feb; 230():153758. PubMed ID: 35026646
[TBL] [Abstract][Full Text] [Related]
64. [Clinical and molecular epidemiology of lymphangioleiomyomatosis and pulmonary pathology in tuberous sclerosis].
Urban T
Rev Mal Respir; 2000 Jun; 17(2 Pt 2):597-603. PubMed ID: 10939121
[TBL] [Abstract][Full Text] [Related]
65. Pulmonary manifestations in tuberous sclerosis complex.
Gupta N; Henske EP
Am J Med Genet C Semin Med Genet; 2018 Sep; 178(3):326-337. PubMed ID: 30055039
[TBL] [Abstract][Full Text] [Related]
66. Diagnostic usefulness of transbronchial lung cryobiopsy in two patients mildly affected with pulmonary lymphangioleiomyomatosis.
Yoshida M; Awano N; Inomata M; Kuse N; Tone M; Yoshimura H; Jo T; Takada K; Kumasaka T; Izumo T
Respir Investig; 2020 Jul; 58(4):295-299. PubMed ID: 32265154
[TBL] [Abstract][Full Text] [Related]
67. Protein expression of urotensin II, urotensin-related peptide and their receptor in the lungs of patients with lymphangioleiomyomatosis.
Kristof AS; You Z; Han YS; Giaid A
Peptides; 2010 Aug; 31(8):1511-6. PubMed ID: 20433884
[TBL] [Abstract][Full Text] [Related]
68. Pulmonary lymphangioleiomyomatosis. A study of 69 patients. Groupe d'Etudes et de Recherche sur les Maladies "Orphelines" Pulmonaires (GERM"O"P).
Urban T; Lazor R; Lacronique J; Murris M; Labrune S; Valeyre D; Cordier JF
Medicine (Baltimore); 1999 Sep; 78(5):321-37. PubMed ID: 10499073
[TBL] [Abstract][Full Text] [Related]
69. Proapoptotic protein Bim attenuates estrogen-enhanced survival in lymphangioleiomyomatosis.
Li C; Li N; Liu X; Zhang EY; Sun Y; Masuda K; Li J; Sun J; Morrison T; Li X; Chen Y; Wang J; Karim NA; Zhang Y; Blenis J; Reginato MJ; Henske EP; Yu JJ
JCI Insight; 2016 Nov; 1(19):e86629. PubMed ID: 27882343
[TBL] [Abstract][Full Text] [Related]
70. Sirolimus Suppresses Phosphorylation of Cofilin and Reduces Interstitial Septal Thickness in Sporadic Lymphangioleiomyomatosis.
Huang YL; Chen PR; Lai YJ; Hsu HH
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445268
[TBL] [Abstract][Full Text] [Related]
71. Chemokine-enhanced chemotaxis of lymphangioleiomyomatosis cells with mutations in the tumor suppressor TSC2 gene.
Pacheco-Rodriguez G; Kumaki F; Steagall WK; Zhang Y; Ikeda Y; Lin JP; Billings EM; Moss J
J Immunol; 2009 Feb; 182(3):1270-7. PubMed ID: 19155472
[TBL] [Abstract][Full Text] [Related]
72. Incidental Nodal Lymphangioleiomyomatosis Is Not a Harbinger of Pulmonary Lymphangioleiomyomatosis: A Study of 19 Cases With Evaluation of Diagnostic Immunohistochemistry.
Schoolmeester JK; Park KJ
Am J Surg Pathol; 2015 Oct; 39(10):1404-10. PubMed ID: 26135558
[TBL] [Abstract][Full Text] [Related]
73. Probability of sporadic lymphangioleiomyomatosis in women presenting with spontaneous pneumothorax.
Suter A; Müller ME; Daccord C; Taffé P; Lazor R
Orphanet J Rare Dis; 2023 Jul; 18(1):180. PubMed ID: 37415209
[TBL] [Abstract][Full Text] [Related]
74. Pulmonary lymphangioleiomyomatosis: A proposed state of neoplastic senescence.
Lombard CM
Med Hypotheses; 2019 Nov; 132():109372. PubMed ID: 31494502
[TBL] [Abstract][Full Text] [Related]
75. Prevalence of uterine and adnexal involvement in pulmonary lymphangioleiomyomatosis: a clinicopathologic study of 10 patients.
Hayashi T; Kumasaka T; Mitani K; Terao Y; Watanabe M; Oide T; Nakatani Y; Hebisawa A; Konno R; Takahashi K; Yao T; Seyama K
Am J Surg Pathol; 2011 Dec; 35(12):1776-85. PubMed ID: 22020043
[TBL] [Abstract][Full Text] [Related]
76. Cathepsin K in Lymphangioleiomyomatosis: LAM Cell-Fibroblast Interactions Enhance Protease Activity by Extracellular Acidification.
Dongre A; Clements D; Fisher AJ; Johnson SR
Am J Pathol; 2017 Aug; 187(8):1750-1762. PubMed ID: 28623674
[TBL] [Abstract][Full Text] [Related]
77. Relapse of Lymphangioleiomyomatosis Five Years after Bilateral-Lung Transplantation.
Heshmatnia J; Mirenayat MS; Rezaei M; Bongomin F; Bakhshayeshkaram M; Tabarsi P; Sheikhy K; Mortezaee V
Arch Iran Med; 2021 Sep; 24(9):701-703. PubMed ID: 34816687
[TBL] [Abstract][Full Text] [Related]
78. Reversible airflow obstruction, proliferation of abnormal smooth muscle cells, and impairment of gas exchange as predictors of outcome in lymphangioleiomyomatosis.
Taveira-DaSilva AM; Hedin C; Stylianou MP; Travis WD; Matsui K; Ferrans VJ; Moss J
Am J Respir Crit Care Med; 2001 Sep; 164(6):1072-6. PubMed ID: 11587999
[TBL] [Abstract][Full Text] [Related]
79. Immunohistological features related to functional impairment in lymphangioleiomyomatosis.
Nascimento ECTD; Baldi BG; Mariani AW; Annoni R; Kairalla RA; Pimenta SP; da Silva LFF; Carvalho CRR; Dolhnikoff M
Respir Res; 2018 May; 19(1):83. PubMed ID: 29739412
[TBL] [Abstract][Full Text] [Related]
80. Immunotherapy for Lymphangioleiomyomatosis and Tuberous Sclerosis: Progress and Future Directions.
Liu HJ; Krymskaya VP; Henske EP
Chest; 2019 Dec; 156(6):1062-1067. PubMed ID: 31437431
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
